Quantinno Capital Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.88M Buy
5,647
+1,629
+41% +$564K ﹤0.01% 2237
2026
Q2
$1.49M Buy
4,018
+847
+27% +$253K ﹤0.01% 2224
2026
Q1
$819K Buy
3,171
+267
+9% +$71K ﹤0.01% 2332
2025
Q4
$716K Buy
2,904
+742
+34% +$156K ﹤0.01% 2064
2025
Q3
$382K Buy
+2,162
New +$324K ﹤0.01% 2252

Other funds holding KRYS

Quantinno Capital Management's KRYS Position: Q3 2026 in Review

Quantinno Capital Management increased its Krystal Biotech (KRYS) stake by 41% in Q3 2026, buying an estimated $564K and bringing the position to 5,647 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2237.

Quantinno Capital Management first reported a position in KRYS in Q3 2025 and has held it in 5 quarters since. 442 funds tracked by Wall St. Rank hold KRYS as of Q3 2026.

  • Quantinno Capital Management held 5,647 shares of Krystal Biotech worth $1.88M as of Q3 2026.
  • Quantinno Capital Management bought 1,629 Krystal Biotech shares in Q3 2026, an estimated $564K.
  • Krystal Biotech made up ﹤0.01% of Quantinno Capital Management's portfolio in Q3 2026, its #2237 holding.
  • Quantinno Capital Management first reported a position in Krystal Biotech in Q3 2025 and has held it in 5 quarters since.
  • 442 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2026.

Based on Quantinno Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.